Inflammation

Inflammation (from Latin inflammare, "to set on fire") is the complex, evolutionarily conserved biological response of vascularized living tissues to harmful stimuli, including microbial pathogens, necrotic cellular debris, chemical irritants, and physical trauma. As a cornerstone of innate immunology, acute inflammation rapidly delivers plasma proteins (such as antibodies, clotting factors, and components of the complement system) and circulating leukocytes (principally neutrophils and monocytes/macrophages) from the intravascular bloodstream across postcapillary venules into the extravascular interstitial site of injury, where professional phagocytes clear the offending agent via phagocytosis and orchestrate tissue regeneration.

In the first century CE, the Roman encyclopedist Aulus Cornelius Celsus codified the four classical clinical signs of acute inflammation in De Medicina: rubor (redness, caused by arteriolar vasodilation and hyperemia), calor (heat, resulting from increased regional blood flow transferring core body warmth to the periphery), tumor (swelling or edema, produced by heightened venular endothelial permeability and protein-rich fluid exudation), and dolor (pain, triggered by mechanical tissue distension and sensitization of nociceptive nerve endings by bradykinin and prostaglandins). In 1858, the German pathologist Rudolf Virchow added the fifth cardinal sign, functio laesa (loss of function), reflecting the combined effects of pain, edema, and parenchymal structural disruption.

PAMPs, DAMPs, TLRs, and the NLRP3 Inflammasome

Acute inflammation is initiated within seconds to minutes when sentinel cells residing in extravascular tissues—primarily tissue-resident macrophages, dendritic cells, and perivascular mast cells—detect conserved molecular signatures via germline-encoded pattern recognition receptors (PRRs). These receptors discriminate between two classes of danger triggers:

1. Pathogen-Associated Molecular Patterns (PAMPs): Essential microbial structures absent from host cells, including Gram-negative bacterial lipopolysaccharide (LPS, recognized by Toll-like receptor 4 [TLR4]), bacterial flagellin (TLR5), unmethylated CpG DNA (TLR9), viral double-stranded RNA (TLR3, RIG-I, and MDA5), and fungal β-glucans (Dectin-1).
2. Damage-Associated Molecular Patterns (DAMPs or Alarmins): Endogenous intracellular molecules released into the extracellular space upon sterile necrotic cell lysis or tissue stress, such as extracellular ATP (acting on purinergic P2X7 ion channels), uric acid monosodium urate crystals (the trigger of gout), high-mobility group box 1 (HMGB1) chromatin protein, and mitochondrial DNA.

Engagement of cell-surface or endosomal TLRs activates the adapter proteins MyD88 and TRIF, triggering phosphorylation and ubiquitin-mediated proteasomal degradation of IκB, which releases the master transcription factor NF-κB to translocate into the nucleus and drive transcription of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) and chemokines (IL-8 / CXCL8, CCL2). Maturation of interleukin-1β (IL-1β) and IL-18 requires a second intracellular step: assembly of the cytosolic multiprotein NLRP3 inflammasome (comprising the sensor NLRP3, the bipartite adapter ASC, and the cysteine protease pro-caspase-1, frequently triggered by K⁺ efflux). Active caspase-1 cleaves biologically inactive pro-IL-1β into mature secreted IL-1β and cleaves gasdermin D, forming plasma membrane pores that mediate inflammatory lytic cell death (pyroptosis).

Preformed, Lipid, and Plasma-Derived Inflammatory Mediators

Starling Forces and Exudate Formation

Within the microcirculation, acute inflammation begins with transient neurogenic vasoconstriction lasting seconds, followed immediately by arteriolar vasodilation mediated by nitric oxide (NO), histamine, and prostacyclin (PGI₂). As precapillary sphincters open, local blood flow surges (active hyperemia, producing rubor and calor) and intravascular hydrostatic pressure (P_c) inside downstream postcapillary venules rises. Simultaneously, histamine, bradykinin, and leukotrienes cause postcapillary venular endothelial cells to contract their actin–myosin cytoskeletons, opening inter-endothelial junctions (0.1–1.0 μm wide).

In accordance with the Starling equation governing microvascular fluid exchange, the combination of elevated capillary hydrostatic pressure (P_c) and loss of the endothelial protein barrier (which drops the osmotic reflection coefficient σ toward zero as albumin leaks into the interstitium, raising interstitial oncotic pressure π_i) drives a massive net outward filtration of protein-rich fluid (exudate, specific gravity > 1.020, contrasting with protein-poor hydrostatic transudate), producing interstitial edema (tumor). As fluid leaves the vessel lumen, red blood cells pack tightly together (stasis), increasing blood viscosity and displacing circulating white blood cells out of the central axial flow stream toward the vessel wall (margination).

The Four-Step Leukocyte Extravasation Cascade

Once marginated along the postcapillary venular wall, circulating leukocytes (neutrophils during the first 6–24 hours, followed by monocytes at 24–48 hours) cross the endothelial barrier via a sequential, four-step molecular adhesion cascade:

1. Tethering and Rolling (Selectins): TNF-α and IL-1β stimulate endothelial cells to mobilize Weibel-Palade bodies (externalizing P-selectin within minutes) and transcribe E-selectin (within 1–2 hours), while leukocytes constitutively express L-selectin. These C-type lectin molecules bind with low affinity and fast off-rates (k_off) to sialylated fucosylated oligosaccharides (sialyl-Lewis X [sLe^x]) on opposing glycoproteins, causing the leukocyte to tether, detach, and roll slowly along the endothelium under hemodynamic shear stress.
2. Chemokine Activation (Inside-Out Integrin Signaling): As the leukocyte rolls, chemokines (such as CXCL8 / IL-8 or CCL2) immobilized on endothelial heparan sulfate proteoglycans bind seven-transmembrane chemokine G protein-coupled receptors (CXCR1/2) on the leukocyte surface. Intracellular Gα_i signaling triggers inside-out activation of leukocyte integrins—specifically LFA-1 (α_Lβ₂ / CD11a-CD18), Mac-1 (α_Mβ₂ / CD11b-CD18), and VLA-4 (α₄β₁)—switching them from a bent, low-affinity conformation to an extended, high-affinity open state within milliseconds.
3. Firm Arrest and Adhesion (Integrins–Ig-Superfamily Ligands): High-affinity LFA-1 and Mac-1 bind tightly to endothelial immunoglobulin-superfamily ligands ICAM-1 (Intercellular Adhesion Molecule-1), while VLA-4 binds VCAM-1 (Vascular Cell Adhesion Molecule-1), bringing the rolling leukocyte to a complete halt and causing it to flatten across the luminal wall.
4. Transendothelial Migration / Diapedesis (PECAM-1) and Chemotaxis: Homophilic interactions between PECAM-1 (CD31) and CD99 on both the leukocyte and the endothelial intercellular junction guide the leukocyte to squeeze paracellularly between endothelial cells, secrete type IV collagenases to pierce the basement membrane, and migrate up a chemical gradient (chemotaxis toward C5a, LTB₄, CXCL8, and bacterial N-formylmethionyl peptides) to the site of infection.

Contrary to early models viewing resolution as passive mediator dilution, termination of acute inflammation is an active biochemical program termed catabasis. As neutrophils clear microbes and undergo apoptosis, lipid mediator synthesis undergoes a class switch from pro-inflammatory prostaglandins/leukotrienes to arachidonic-, eicosapentaenoic- (EPA), and docosahexaenoic-acid (DHA)-derived Specialized Pro-Resolving Mediators (SPMs)—including lipoxins (LXA₄), resolvins, protectins, and maresins. SPMs halt further neutrophil recruitment and stimulate non-phlogistic efferocytosis (macrophage clearance of apoptotic neutrophils), polarizing macrophages from a pro-inflammatory M1 phenotype toward a tissue-repair M2 phenotype that secretes TGF-β, IL-10, and VEGF to drive angiogenesis and fibroblast collagen deposition.

If the inciting agent cannot be eradicated (e.g., intracellular Mycobacterium tuberculosis, Treponema pallidum, persistent foreign bodies like silica or suture material, or self-antigens in autoimmune diseases like rheumatoid arthritis), the response transitions into chronic inflammation, characterized by simultaneous tissue destruction, mononuclear infiltration (macrophages, lymphocytes, and plasma cells), and fibrosis. In granulomatous inflammation, CD4⁺ Th1 T cells secrete interferon-γ (IFN-γ) and TNF-α to wall off indigestible pathogens inside a spherical granuloma composed of transformed epithelioid macrophages and multinucleated Langhans giant cells surrounded by a collar of lymphocytes and fibroblasts.

How do nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen and aspirin differ from corticosteroids?

NSAIDs (ibuprofen, naproxen, and aspirin—which irreversibly acetylates Ser⁵³⁰) selectively inhibit cyclooxygenase-1 and -2 (COX-1/COX-2), blocking the conversion of arachidonic acid into prostaglandins (PGE₂, PGI₂) and thromboxanes while leaving the 5-lipoxygenase leukotriene pathway intact. Glucocorticoid corticosteroids (prednisone, dexamethasone) act further upstream: they bind intracellular glucocorticoid nuclear receptors both to trans-repress NF-κB and AP-1 (suppressing TNF-α, IL-1β, and COX-2 transcription) and to induce annexin A1 (lipocortin-1), which inhibits phospholipase A₂ (PLA₂), cutting off the release of arachidonic acid for both prostaglandin and leukotriene synthesis.

What is Leukocyte Adhesion Deficiency (LAD), and how does it demonstrate the extravasation cascade?

Leukocyte Adhesion Deficiency comprises rare autosomal recessive primary immunodeficiencies characterized by recurrent, necrotic bacterial infections with a complete absence of pus (neutrophils) in infected tissues alongside marked blood neutrophilia. LAD-1 is caused by mutations in ITGB2 (encoding the CD18 β₂-integrin subunit of LFA-1 and Mac-1), abolishing firm endothelial arrest (Step 3). LAD-2 results from mutations in a Golgi GDP-fucose transporter (SLC35C1), preventing synthesis of the sialyl-Lewis X carbohydrate ligand required for selectin-mediated rolling (Step 1).

Why does TNF-α inhibition treat rheumatoid arthritis and Crohn's disease but risk reactivating latent tuberculosis?

In autoimmune disorders such as rheumatoid arthritis and Crohn's disease, excessive TNF-α drives chronic endothelial adhesion molecule expression, synovial pannus proliferation, and matrix metalloproteinase tissue destruction; monoclonal anti-TNF-α antibodies (infliximab, adalimumab) block this cascade. However, in patients with latent Mycobacterium tuberculosis, continuous TNF-α signaling is required to maintain the structural integrity and macrophage activation of containment granulomas; neutralizing TNF-α causes granulomas to disintegrate, allowing dormant mycobacteria to disseminate.

1. Medzhitov, R. (2008). "Origin and physiological roles of inflammation." Nature, 454(7203), 428–435. https://doi.org/10.1038/nature07201
2. Ley, K., Laudanna, C., Cybulsky, M. I., & Nourshargh, S. (2007). "Getting to the site of inflammation: the leukocyte adhesion cascade updated." Nature Reviews Immunology, 7(9), 678–689. https://doi.org/10.1038/nri2156
3. Serhan, C. N. (2014). "Pro-resolving lipid mediators are leads for resolution physiology." Nature, 510(7503), 92–101. https://doi.org/10.1038/nature13479
4. Takeuchi, O., & Akira, S. (2010). "Pattern recognition receptors and inflammation." Cell, 140(6), 805–820. https://doi.org/10.1016/j.cell.2010.01.022